Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
By
Bailey B. Banach,
Gabriele Cerutti,
Ahmed S. Fahad,
Chen-Hsiang Shen,
Matheus Oliveira de Souza,
Phinikoula S. Katsamba,
Yaroslav Tsybovsky,
Pengfei Wang,
Manoj S. Nair,
Yaoxing Huang,
Irene M. Francino Urdániz,
Paul J Steiner,
Matias Gutiérrez-González,
Lihong Liu,
Sheila N. López Acevedo,
Alexandra Nazzari,
Jacy R. Wolfe,
Yang Luo,
Adam S. Olia,
I-Ting Teng,
Jian Yu,
Tongqing Zhou,
Eswar R. Reddem,
Jude Bimela,
Xiaoli Pan,
Bharat Madan,
Amy D. Laflin,
Rajani Nimrania,
Kwon-Tung Yuen,
Timothy A. Whitehead,
David D Ho,
Peter D. Kwong,
Lawrence Shapiro,
Brandon J. DeKosky
Posted 03 Jan 2021
bioRxiv DOI: 10.1101/2020.12.31.424987
Understanding protective mechanisms of antibody recognition can inform vaccine and therapeutic strategies against SARS-CoV-2. We discovered a new antibody, 910-30, that targets the SARS-CoV-2 ACE2 receptor binding site as a member of a public antibody response encoded by IGHV3-53/IGHV3-66 genes. We performed sequence and structural analyses to explore how antibody features correlate with SARS-CoV-2 neutralization. Cryo-EM structures of 910-30 bound to the SARS-CoV-2 spike trimer revealed its binding interactions and ability to disassemble spike. Despite heavy chain sequence similarity, biophysical analyses of IGHV3-53/3-66 antibodies highlighted the importance of native heavy:light pairings for ACE2 binding competition and for SARS-CoV-2 neutralization. We defined paired heavy:light sequence signatures and determined antibody precursor prevalence to be ~1 in 44,000 human B cells, consistent with public antibody identification in several convalescent COVID-19 patients. These data reveal key structural and functional neutralization features in the IGHV3-53/3-66 public antibody class to accelerate antibody-based medical interventions against SARS-CoV-2. HighlightsO_LIA molecular study of IGHV3-53/3-66 public antibody responses reveals critical heavy and light chain features for potent neutralization C_LIO_LICryo-EM analyses detail the structure of a novel public antibody class member, antibody 910-30, in complex with SARS-CoV-2 spike trimer C_LIO_LICryo-EM data reveal that 910-30 can both bind assembled trimer and can disassemble the SARS-CoV-2 spike C_LIO_LISequence-structure-function signatures defined for IGHV3-53/3-66 class antibodies including both heavy and light chains C_LIO_LIIGHV3-53/3-66 class precursors have a prevalence of 1:44,000 B cells in healthy human antibody repertoires C_LI
Download data
- Downloaded 474 times
- Download rankings, all-time:
- Site-wide: 52,632
- In immunology: 1,420
- Year to date:
- Site-wide: 1,251
- Since beginning of last month:
- Site-wide: 1,251
Altmetric data
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!